Brief: Acura Pharmaceuticals Says Co Engaged Catalent Pharma Solutions To Initiate Manufacturing Scale-Up Of LTX-03 Tablets
09/09/2019 12:09
Sept 9 (Reuters) - Acura Pharmaceuticals Inc ACUR.PK :
* ACURA PHARMACEUTICALS - ENGAGED CATALENT PHARMA SOLUTIONS
TO
INITIATE MANUFACTURING SCALE-UP OF LTX-03 TABLETS TO ULTIMATELY
BE USED IN CLINICAL TESTING
Source text for Eikon: ID:nGNX9ktjdn
Further company coverage: ACUR.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acura Pharmaceuticals
See all newsBrief: Acura Pharmaceuticals Received A $250,000 Loan From Abuse Deterrent Pharma, LLC on October 11
Brief: Acura Pharmaceuticals Inc Receives $200,000 Loan From Abuse Deterrent Pharma
Brief: Acura Pharmaceuticals Received $250,000 Loan From AD Pharma For Operations Through End Of April 2023
Brief: Acura Pharmaceuticals, AD Pharma Amend License to LIMITx LTX-03
Insight: Novavax bosses cash out for $46 mln with COVID-19 vaccine trials still under way